Losartan recall - Legacy Pharmaceuticals

On April 25th 2019, Legacy Pharmaceuticals announced an expansion of their recall of Losartan 50mg Tablets to a total of 4 lots due to the detection of an unexpected impurity found in the active pharmaceutical ingredient manufactured by Hetero Labs Limited.

Additional information is available on the FDA's website:

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/legacy-pharmaceutical-packaging-llc-expands-voluntary-nationwide-recall-losartan-potassium-tablets